These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8255836)

  • 1. Serum soluble interleukin 2 receptor levels in anti-neutrophil cytoplasmic autoantibodies--positive systemic vasculitis.
    Lai KN; Lockwood CM
    Postgrad Med J; 1993 Sep; 69(815):708-11. PubMed ID: 8255836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse.
    Sanders JS; Huitma MG; Kallenberg CG; Stegeman CA
    Ann Rheum Dis; 2006 Nov; 65(11):1484-9. PubMed ID: 16504995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell activation in patients with ANCA-associated vasculitis: inefficient immune suppression by therapy.
    Christensson M; Pettersson E; Sundqvist KG; Christensson B
    Clin Nephrol; 2000 Dec; 54(6):435-42. PubMed ID: 11140803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of anti-endothelial cell antibodies in systemic vasculitis: a longitudinal study comparing anti-endothelial cell antibodies and anti-neutrophil cytoplasm antibodies.
    Chan TM; Frampton G; Jayne DR; Perry GJ; Lockwood CM; Cameron JS
    Am J Kidney Dis; 1993 Sep; 22(3):387-92. PubMed ID: 8372833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sensitivity and specificity of antineutrophil cytoplasmic antibodies in systemic vasculitis].
    Hachulla E; Hatron PY; Brouillard M; Cesbron JY; Reumaux D; Devulder B
    Rev Med Interne; 1994 May; 15(6):381-6. PubMed ID: 7914710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of CD25 and adhesion molecules on peripheral blood lymphocytes of patients with Wegener's granulomatosis (WG) and ANCA positive vasculitides.
    Gutfleisch J; Baumert E; Wolff-Vorbeck G; Schlesier M; Strutz HJ; Peter HH
    Adv Exp Med Biol; 1993; 336():397-404. PubMed ID: 7507630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum markers of T cell activation in relapses of Wegener's granulomatosis.
    Stegeman CA; Tervaert JW; Huitema MG; Kallenberg CG
    Clin Exp Immunol; 1993 Mar; 91(3):415-20. PubMed ID: 8443965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANCA-associated vasculitides. Immunological and clinical aspects. Proceedings of the 4th International Workshop on ANCA and the 2nd International Colloquium on Wegener's Granulomatosis and Vasculitic Disorders. May 28-30, 1992, Lübeck, Germany.
    Adv Exp Med Biol; 1993; 336():1-549. PubMed ID: 8296595
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of the titration of anti-neutrophil cytoplasmic antibodies in therapeutic follow-up of patients with systemic vasculitis].
    Bergelin A; Subra JF; Carrere F; Chevailler A; Masson C; Szapiro N; Riberi P
    Rev Med Interne; 1993; 14(10):1024. PubMed ID: 8009020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pathological manifestations of patients with antineutrophil cytoplasmic autoantibodies directed against proteinase 3 or myeloperoxidase.
    Zhang X; Dong Y; Zeng X; Li Y; Tang F
    Chin Med Sci J; 2002 Mar; 17(1):32-5. PubMed ID: 12894882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis.
    Gaskin G; Savage CO; Ryan JJ; Jones S; Rees AJ; Lockwood CM; Pusey CD
    Nephrol Dial Transplant; 1991; 6(10):689-94. PubMed ID: 1754104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin.
    Jayne DR; Esnault VL; Lockwood CM
    J Autoimmun; 1993 Apr; 6(2):207-19. PubMed ID: 8499059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.
    Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN
    Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
    Radice A; Vecchi M; Bianchi MB; Sinico RA
    Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and histopathological association of 29kD-ANCA and MPO-ANCA.
    Tervaert JW; Elema JD; Kallenberg CG
    APMIS Suppl; 1990; 19():35. PubMed ID: 2178358
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic bronchial suppuration and antineutrophil cytoplasmic antibody (ANCA) positive systemic vasculitis.
    Sitara D; Hoffbrand BI
    Postgrad Med J; 1990 Aug; 66(778):669-71. PubMed ID: 2217039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of antineutrophil cytoplasmic autoantibody-positive systemic vasculitis and glomerulonephritis with pooled intravenous gammaglobulin.
    Tuso P; Moudgil A; Hay J; Goodman D; Kamil E; Koyyana R; Jordan SC
    Am J Kidney Dis; 1992 Nov; 20(5):504-8. PubMed ID: 1442764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rise in antineutrophil cytoplasmic antibody in a patient with systemic vasculitis in remission.
    Kaname S; Uchida S; Minoda S; Arimura Y; Nagasawa T; Asano S; Ogata E
    Nephron; 1994; 68(3):380-4. PubMed ID: 7838265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA).
    Talor MV; Stone JH; Stebbing J; Barin J; Rose NR; Burek CL
    Clin Exp Immunol; 2007 Oct; 150(1):42-8. PubMed ID: 17614969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.